Piera Smeriglio will take over the management of the BOND Group – Biotherapies for motor neuron disorders (ALS & SMA) following the upcoming departure of Maria Grazia Biferi to whom we send our best wishes and whom we warmly thank for the work she has done with her group within the framework of the Myology Centre For Research.
The main goal of the BOND-group is to develop new therapies for motor neuron disorders (MND). The group members are focused on spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
